NWBO OTC
Bethesda, MD 20814
US
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| BOYNTON ALTON L | G-Gift | 1,000,000 | $0.23 | 2024-08-29 |
| BOSCH MARNIX L | G-Gift | 3,000,000 | $0.35 | 2024-08-09 |
| BOYNTON ALTON L | G-Gift | 1,000,000 | $0.23 | 2024-08-08 |
| MALIK NAVID | S-Sale | 657,895 | $0.23 | 2024-07-26 |
| MALIK NAVID | S-Sale | 150,000 | $0.82 | 2023-11-17 |